Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Mianserin HCl in Applied Research: Protocols & Optimization
2026-05-20
Mianserin HCl, a selective 5-HT2 receptor antagonist, is reshaping antidepressant and antipathogenic research with its unique receptor profile and complexation chemistry. This guide translates core findings from bench to workflow, offering stepwise protocols, troubleshooting, and strategic insights for maximizing the compound’s utility in advanced neuroscience and cell-based assays.
-
Ricin-Induced Bystander Necroptosis in Lung Epithelium: Mech
2026-05-20
Kempen et al. (2023) delineate a novel mechanism of bystander necroptosis in lung epithelial cells triggered by ricin toxin exposure and macrophage-derived inflammatory mediators. Their findings highlight the distinct contributions of released FasL, HMGB1, and reactive oxygen species in propagating inflammatory cell death, informing future strategies for toxin-induced lung injury research.
-
Iptacopan (LNP023): Applied Protocols for Alternative Pathwa
2026-05-19
Iptacopan (LNP023) empowers precise inhibition of complement factor B, enabling robust translational workflows in hemolysis assays and animal models of complement-mediated disease. This guide details actionable protocols, troubleshooting strategies, and data-driven insights to accelerate complement activation research.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Proto
2026-05-19
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents proteolytic degradation during protein extraction, especially where divalent cation preservation is required. It is best used in workflows such as Western blotting, co-immunoprecipitation, and phosphorylation-sensitive assays. It should be avoided in applications where EDTA is specifically needed for chelation.
-
Ouabain in Translational Research: From Na⁺/K⁺-ATPase Inhibi
2026-05-18
Explore how Ouabain, a selective Na⁺/K⁺-ATPase inhibitor, is redefining translational research by bridging ion transport, cardiovascular models, and machine learning-driven senolytic discovery. This article offers a unique systems-level analysis and practical guidance for advanced assay design.
-
Decitabine in Autoantigen Reactivation: Epigenetic Frontiers
2026-05-18
Explore how Decitabine (5-Aza-2'-deoxycytidine) not only reactivates tumor suppressor genes but also reveals new horizons in autoantigen discovery for cancer and autoimmune research. This article provides an in-depth analysis, bridging foundational epigenetic mechanisms with advanced translational applications.
-
Irinotecan (CPT-11) in Colorectal Cancer: Workflows & Optimi
2026-05-17
Irinotecan (CPT-11) redefines experimental precision in colorectal cancer research through its validated mechanism of topoisomerase I inhibition and robust performance in both in vitro and in vivo models. This article delivers actionable protocols, advanced troubleshooting, and critical appraisals—enabling researchers to maximize assay reproducibility and translational relevance.
-
Anagliptin-Induced Vasorelaxation via Kv Channels and SERCA
2026-05-16
This study demonstrates that Anagliptin (SK-0403) induces vasorelaxation in rabbit aortic smooth muscle by selectively activating voltage-dependent K+ (Kv) channels and the SERCA pump, independently of endothelium and classical cAMP/cGMP pathways. These mechanistic insights clarify Anagliptin's vascular actions and inform experimental models for diabetes and cardiovascular research.
-
Protoporphyrin IX: Precision Photodynamic Compound in Ferrop
2026-05-15
Explore the pivotal role of Protoporphyrin IX as a photodynamic compound in heme formation and ferroptosis resistance. This article offers an advanced, practical guide for experimentalists, integrating the latest cancer research insights and highlighting APExBIO's rigorous standards.
-
LAG-3/TCR Proximity Directs T Cell Suppression in Autoimmuni
2026-05-15
This study elucidates how spatial proximity between LAG-3 and the T cell receptor (TCR) is essential for effective suppression of T cell activation and autoimmunity. The findings introduce a bispecific antibody strategy that targets both LAG-3 and TCR, offering a refined checkpoint modulation mechanism with translational potential for autoimmune disease intervention.
-
Danazol (SKU C3644): Reliable Solutions for Endocrine Assays
2026-05-14
This article explores real-world laboratory challenges in cell viability, proliferation, and hormone signaling assays, illustrating how Danazol (SKU C3644) from APExBIO delivers reproducible and mechanistically robust results. Researchers will find scenario-driven Q&A blocks, protocol guidance, and evidence-backed comparisons to optimize assay performance and data integrity.
-
Protein A/G Magnetic Co-IP/IP Kit: Advanced Protein Complex
2026-05-14
The Protein A/G Magnetic Co-IP/IP Kit streamlines co-immunoprecipitation workflows for protein-protein interaction analysis with unmatched specificity and reproducibility. Optimized for both standard and challenging biological samples, this kit accelerates discovery in neurodegenerative and translational research.
-
HRP Rabbit Anti-Goat IgG (H+L) Antibody: Optimizing Immunode
2026-05-13
Unlock unparalleled sensitivity in immunodetection of goat primary antibodies with the HRP Rabbit Anti-Goat IgG (H+L) Antibody. This guide delivers actionable protocol enhancements, troubleshooting strategies, and translational insights for pulmonary toxicity research and beyond.
-
Distinct Palonosetron Dissociation at 5-HT3A vs. 5-HT3AB Rec
2026-05-13
This study investigates how palonosetron, a 5-HT3 receptor antagonist, exhibits unique ligand-dependent dissociation kinetics at different 5-HT3 receptor subtypes. The findings clarify mechanistic reasons for palonosetron's prolonged antiemetic efficacy and provide key numeric benchmarks for translational and in vitro research.
-
Fosinopril Sodium: Distinct Pharmacokinetics and Strategic U
2026-05-12
Explore how Fosinopril sodium, a third-generation ACE inhibitor, offers unique pharmacokinetic advantages and research versatility. This article provides advanced guidance for hypertension and cardiovascular modeling, grounded in primary evidence and comparative analysis.